Clarithromycin Tablet
Product Images NDC 71335-1493

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 71335-1493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clarithrofigure2 (Clarithromycinfigure2)

This is a graph displaying the mean plasma concentration of Clarithromycin Extended-release (2 x 500 mg g24h) and Clarithromycin (500 mg q12h) over 24 hours after dosing. The x-axis shows the time after dosing in hours while the y-axis shows the mean plasma concentration in mcg/mL.*

FDA Label Image

Chemicalstructure (Clarithromycin)

FDA Label Image

Figure3 (Figure3)

The text describes a graph showing the proportion surviving over a period of 700 days since randomization. Two treatments are compared, clarithromycin and placebo, with the clarification treatment showing higher survival rates.*

FDA Label Image

Label Image (Lbl713351493)

This is a description of a medication named "Clarithromycin Tablets, USP" with VSN #0516 YO. Each tablet contains 500mg of Clarithromycin, USP. The medication should be stored at 20° to 25° C (68° to 77° F), and excursions permitted to 15° to 30° C (59° to 86° F). It is also advised to keep the medication out of children's reach. The NDC number of this medication is 71335-1493-1. Consumers should finish all the medication and take it with food.*

FDA Label Image

Lbl7133514932

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.